1. Home
  2. QNST vs VIR Comparison

QNST vs VIR Comparison

Compare QNST & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuinStreet Inc.

QNST

QuinStreet Inc.

HOLD

Current Price

$14.44

Market Cap

792.3M

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$5.84

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNST
VIR
Founded
1999
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
792.3M
825.0M
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
QNST
VIR
Price
$14.44
$5.84
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$25.75
$25.73
AVG Volume (30 Days)
613.9K
2.1M
Earning Date
02-05-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
$1,100,345,000.00
$16,860,000.00
Revenue This Year
$11.73
N/A
Revenue Next Year
$9.82
$48.05
P/E Ratio
$81.44
N/A
Revenue Growth
43.12
N/A
52 Week Low
$12.98
$4.16
52 Week High
$25.50
$14.45

Technical Indicators

Market Signals
Indicator
QNST
VIR
Relative Strength Index (RSI) 49.94 42.12
Support Level $14.43 $6.49
Resistance Level $15.08 $6.75
Average True Range (ATR) 0.49 0.48
MACD 0.04 -0.09
Stochastic Oscillator 39.58 18.63

Price Performance

Historical Comparison
QNST
VIR

About QNST QuinStreet Inc.

QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia. Geographically, it operates in United States and Internationally, of which maximum revenue is derived from United States.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: